Gareth Willis

Gareth Willis is an experienced professional currently serving as Chief Executive Officer at Exosla Therapeutics since June 2025 and as Key Account Director at BenchSci since November 2024. Additionally, Gareth holds the position of Chief Operating Officer at Otologic Pharmaceutics and previously worked as Asset & Scientific Evaluation Lead at invoX. Prior to these roles, Gareth was a Principal Scientist and Associate Director at Boehringer Ingelheim and a Fellow in Vertex Cell and Gene Therapy at Vertex Pharmaceuticals. Academic contributions include lectureship positions at Harvard Medical School and teaching roles at Boston Children's Hospital, complemented by a post-doctoral research associate role at Cardiff University. Gareth's educational background includes a Fellowship in Pharmacology from Harvard Medical School and a PhD in Molecular and Experimental Medicine from Cardiff University.